We are international
Donate
TEXT SIZE   


ASH 2012: Dr. Hou- A Multi-Center, Open-Label Phase II Study of Lenalidomide Plus Low-Dose Dexamethasone in Chinese Patients with Relapsed/Refractory Multiple Myeloma - the MM-021 Trial
Jian Hou, PhD
Chang Zheng Hospital, Second Military Medical University
Shanghai, China
12.02.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles